Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) EBT (2018 - 2025)

TransMedics has reported EBT over the past 8 years, most recently at -$84.7 million for Q4 2025.

  • Quarterly results put EBT at -$84.7 million for Q4 2025, down 1312.18% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 96.73% YoY), and the annual figure for FY2025 was $1.2 million, down 96.73%.
  • EBT for Q4 2025 was -$84.7 million at TransMedics, down from $23.0 million in the prior quarter.
  • Over the last five years, EBT for TMDX hit a ceiling of $36.2 million in Q2 2025 and a floor of -$84.7 million in Q4 2025.
  • Median EBT over the past 5 years was -$1.8 million (2023), compared with a mean of -$1.3 million.
  • Biggest five-year swings in EBT: soared 1340.1% in 2024 and later crashed 1312.18% in 2025.
  • TransMedics' EBT stood at $31.7 million in 2021, then crashed by 121.95% to -$7.0 million in 2022, then soared by 155.57% to $3.9 million in 2023, then skyrocketed by 80.92% to $7.0 million in 2024, then crashed by 1312.18% to -$84.7 million in 2025.
  • The last three reported values for EBT were -$84.7 million (Q4 2025), $23.0 million (Q3 2025), and $36.2 million (Q2 2025) per Business Quant data.